BLIFASEND

Serial Number 99105159
Registration 8013677
700

Registration Progress

Application Filed
Mar 26, 2025
Under Examination
Approved for Publication
Sep 16, 2025
Published for Opposition
Sep 16, 2025
Registered
Nov 4, 2025

Trademark Image

BLIFASEND

Basic Information

Serial Number
99105159
Registration Number
8013677
Filing Date
March 26, 2025
Registration Date
November 4, 2025
Published for Opposition
September 16, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 4, 2025
Registration
Registered
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG12NY
GB

Ownership History

Glaxo Group Limited

Original Applicant
99
Stevenage GB

Glaxo Group Limited

Owner at Publication
99
Stevenage GB

Glaxo Group Limited

Original Registrant
99
Stevenage GB

Legal Representation

Attorney
Christopher M. Hanes

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Nov 4, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 4, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 16, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 16, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 10, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 15, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 14, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 14, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 14, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Aug 8, 2025 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 8, 2025 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Aug 8, 2025 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 7, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 26, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 26, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 26, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

Classification

International Classes
005